Latest Regulatory News

Breakthrough Minerals Limited has voluntarily suspended trading on the ASX as it prepares to announce a significant mineral project acquisition and capital raising. The suspension is set to last until the announcement or the resumption of trading on 30 October 2025.

Stavely Minerals Limited reported a net cash outflow from operations of AUD 1.264 million for Q3 2025 but bolstered its cash reserves through financing activities, ending the quarter with AUD 1.722 million. The company signals a strategic reduction in exploration expenditure for the upcoming quarter to sustain operations.

Mount Hope Mining has raised $2.48 million through a placement and share purchase plan to accelerate drilling at its Mt Solitary gold prospect and the broader 7.5km gold corridor in the prolific Cobar Basin.

Atomo Diagnostics reported strong commercial momentum in Q1 FY26, highlighted by a key FDA submission for its FebriDx test and a successful capital raise of $1.3 million. The company also showcased promising clinical data for its Active Syphilis test and expanded its HIV Self-Test distribution channels.

Rincon Resources has completed a significant drilling campaign at its Telfer South Gold Project, testing extensions well beyond its initial resource footprint, while early Laverton drilling results show modest gold grades. Assay results expected soon will be pivotal for the company’s next exploration phase.

Smart Parking Limited reports a record FY25 with revenues up 42% to $77.2 million, driven by organic growth and strategic acquisitions including Peak Parking in the US. The company targets 3,000 managed sites by 2028, leveraging proprietary AI technology across multiple international markets.

CVC Limited is contemplating a fresh offer of Capital Notes, potentially including a reinvestment option for existing holders, contingent on market and regulatory conditions.

Neurizon Therapeutics has secured FDA clearance to resume clinical trials for its lead ALS drug NUZ-001, alongside a $5.2 million capital raise and a key licensing deal with Elanco Animal Health. These developments position the company for a critical growth phase in neurodegenerative disease therapeutics.

Challenger Limited has welcomed APRA’s proposed capital standards for longevity products, highlighting their potential to reduce capital requirements and stimulate growth in Australia’s retirement income sector.

FIN Resources Limited has executed a binding agreement to acquire the fully permitted, high-grade Cabin Lake Gold Project in Canada’s Northwest Territories, setting the stage for immediate exploration and resource growth.

BlinkLab has completed its U.S. autism pilot study with strong diagnostic accuracy and expanded its pivotal FDA trial to seven leading research centers, positioning itself for regulatory submission in late 2026.

Southern Palladium Limited has launched a Share Purchase Plan allowing eligible shareholders to invest up to $30,000 at $1.10 per share, aiming to raise $1 million to advance its Bengwenyama mine project in South Africa.